The study revealed that among CRC patients with KRAS mutations, those with higher TMB (TMB > 10 mutations per Mb) had a longer OS compared to the ones with lower TMB (TMB ≤ 10 mutations per Mb) [84]. The gene discussed is KRAS; the disease is colorectal carcinoma.